Catheter Precision (VTAK) investor relations material

Executive summary

• Special Meeting scheduled for April 15, 2026, to vote on six key proposals impacting capital structure and governance.

• Proposals include authorizations for new share issuances, a reverse stock split, and potential adjournment to solicit additional votes.

• Board recommends voting in favor of all proposals to support financing, acquisitions, and compliance with NYSE American rules.

• Forward-looking statements highlight risks if proposals are not approved, including financing challenges and potential dilution.

Voting matters and shareholder proposals

• Proposal 1: Approve issuance of shares underlying Series C Preferred Stock, potentially exceeding 19.99% of outstanding shares.

• Proposal 2: Approve issuance of shares underlying Series D Preferred Stock for FLYTE and Ponderosa Air acquisitions.

• Proposal 3: Approve issuance of shares underlying Series J Preferred Stock, converting royalty rights held by insiders.

• Proposal 4: Approve additional shares due to reduced conversion price of Series B Preferred Stock.

• Proposal 5: Approve a reverse stock split at a ratio between 1-for-2 and 1-for-100, at Board discretion.

• Proposal 6: Approve adjournment or postponement of the meeting to solicit more votes if needed.

Board of directors and corporate governance

• Board unanimously recommends voting “FOR” all proposals.

• Independent directors approved insider-related transactions, with interested parties abstaining.

• Board retains discretion on timing and ratio of reverse stock split.